4basebio PLC (AIM: 4BB)
Health Care · Biotechnology · GB
£5.63
0.00% today · -27.4% 1Y
4basebio PLC (AIM: 4BB) operates in the Biotechnology industry within the Health Care sector. The company is valued at $115.64M.
Over the last twelve months the share price has lost 27.4%, trading between 4.20 and 8.20.
Tweenvest scores 4basebio PLC across four factors: quality 31/100, value 38/100, growth 100/100. Its strongest factor is growth.
4BB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $115.64M
- Revenue (TTM)
- $1.04M
- P/E
- —
- EPS
- -1.16
- Dividend yield
- —
- Beta (5Y)
- 0.81
- 52-week high
- £8.20
- 52-week low
- £4.20
- Avg volume (3M)
- —
- Shares outstanding
- 15.54M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Aroa Biosurgery LimitedASX: ARX | $117.80M | AU$0.49 | -3.92% |
| Unicycive Therapeutics, Inc.NasdaqCM: UNCY | $117.55M | $4.18 | -0.95% |
| Great Novel Therapeutics Biotech & MedicalsTPEX: 7427 | $116.78M | NT$70.30 | -0.85% |
| ISU Abxis Co., Ltd.KOSDAQ: A086890 | $116.41M | ₩3,845.00 | +9.08% |
| Genelux CorporationNasdaqCM: GNLX | $114.72M | $2.52 | -1.56% |
| Tenax Therapeutics, Inc.NasdaqCM: TENX | $113.42M | $1.91 | -3.54% |
| Hamlet BioPharma AB (publ)XSAT: HAMLET B | $113.40M | Skr6.08 | +1.50% |
| Kintor Pharmaceutical LimitedSEHK: 9939 | $112.96M | HK$1.80 | -2.71% |
Figures last refreshed Oct 4, 2026.